Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.42 |
| ▸ | FDPS | P14324 | 8/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7782349 | 1.00 | CES2 (0.45) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL11839460 | 1.00 | CES2 (0.45) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL22117082 | 0.96 | CES2 (0.42) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL27813236 | 0.91 | FDPS (0.37) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL7621006 | 0.90 | CES2 (0.41) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL141053 | 0.89 | MEN1 (0.40) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL7621003 | 0.86 | MEN1 (0.39) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL28473661 | 0.85 | MEN1 (0.38) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL27833347 | 0.85 | NAAA (0.44) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL11839463 | 0.84 | CES2 (0.44) | CES2MEN1KMT2AGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544086-B2 | Dialkyl carbonates of branched alcohols and their use | COGNIS IP MANAGEMENT GMBH (DE) | 2020-01-28 | — | — | US | disclosed |
| US-20170260123-A1 | DIALKYL CARBONATES OF BRANCHED ALCOHOLS AND THEIR USE | COGNIS IP MANAGEMENT GMBH (DE) | 2017-09-14 | — | — | US | disclosed |
| US-20100331565-A1 | Dialkyl Carbonates of Branched Alcohols and their Use | COGNIS IP MANAGEMENT GMBH (DE) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544086-B2 | Dialkyl carbonates of branched alcohols and their use | ADH1C, ADH1A, GALK1 | CES2 800/4885MEN1 1951/4885MAPT 2333/4885 |
| US-20170260123-A1 | DIALKYL CARBONATES OF BRANCHED ALCOHOLS AND THEIR USE | ADH1C, ADH1A, GALK1 | CES2 800/4885MEN1 1951/4885MAPT 2333/4885 |
| US-20100331565-A1 | Dialkyl Carbonates of Branched Alcohols and their Use | GALK1, BCKDK, ADH1C | CES2 573/4885MEN1 2748/4885MAPT 2323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.